摘要
本文概要介绍小肠细菌过度生长(small intestinal bacterial overgrowth,SIBO)和低度炎症在肠易激综合征患者中的发生率、SIBO的致病作用、利福昔明治疗伴有SIBO的肠易激综合征患者的疗效以及对利福昔明治疗失败的患者的补救治疗方法。
The incidence and pathogenesis of small intestinal bacterial overgrowth(SIBO)and low-grade inflammatory response in irritable bowel syndrome(IBS)patients are introduced.The effects of rifaximin on IBS patients with SIBO and the remedial treatment for rifaximin-resistant IBS patients are also discussed.
作者
陈坚
邱志兵
张会禄
汤子慧
杨冬琴
CHEN Jian;Qiu Zhibing;Zhang Huilu;Tang Zihui;Yang Dongqin(Department of Digestive Disease,Huashan Hospital,Fudan University,Shanghai 200040,China)
出处
《上海医药》
CAS
2019年第15期7-10,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
肠易激综合征
小肠细菌过度生长
乳果糖呼气试验
低度炎症
利福昔明
irritable bowel syndrome
small intestinal bacterial overgrowth
lactulose breath test
low-grade inflammation
rifaximin
